XML 32 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes  
Income Taxes

11. Income Taxes

Provision (Benefit) for Income Taxes

Our provision (benefit) for income taxes relating to continuing operations consists of the following (in thousands):

December 31,

 

    

2022

    

2021

    

2020

 

Current tax provision—

Federal

$

58,040

$

31,283

$

36,556

State

 

26,376

 

8,741

 

12,798

Total current

 

84,416

 

40,024

 

49,354

Deferred tax provision (benefit)—

Federal

 

(80,130)

 

6,197

 

(5,483)

State

 

(14,375)

 

705

 

(2,470)

Total deferred

 

(94,505)

 

6,902

 

(7,953)

Provision (benefit) for income taxes

$

(10,089)

$

46,926

$

41,401

The provision (benefit) for income taxes for the years ended December 31, 2022, 2021 and 2020 resulted in effective tax rates on continuing operations of (4.3%), 24.7% and 21.6%, respectively. The reasons for the differences between these effective tax rates and the federal statutory rates are as follows (in thousands, except percentages):

December 31,

 

    

2022

    

2021

    

2020

 

Federal statutory rate of—

21

%

21

%

21

%

Income taxes at the federal statutory rate

$

49,530

$

39,958

$

40,223

Increases (decreases) resulting from—

Net state income taxes

 

9,376

 

7,340

 

8,406

Valuation allowances

 

(95)

 

(39)

 

(254)

Net unrecognized tax benefits

 

(17,922)

 

640

 

18,557

Nondeductible expenses

 

4,045

 

2,381

 

2,470

R&D tax credit

 

(51,398)

 

 

(26,133)

179D deduction

(964)

(1,207)

(1,062)

Stock-based compensation deductions

(872)

(2,210)

(426)

Other

 

(1,789)

 

63

 

(380)

Provision (benefit) for income taxes

$

(10,089)

$

46,926

$

41,401

During the third quarter of 2020, the Internal Revenue Service (the “IRS”) completed their examination of our amended federal returns for 2014 and 2015 and issued a Revenue Agent Report (“RAR”) allowing the $8.9 million of refund claims in full. Subsequently, the Joint Committee on Taxation (the “JCT”) reviewed and approved the refund claims. As a result, our provision for income taxes was decreased by $8.3 million due to a reduction in unrecognized tax benefits.

In early October 2020, we filed amended federal returns for 2016, 2017 and 2018 primarily to claim the credit for increasing research activities (the “R&D tax credit”) requesting refunds of $9.8 million, $9.5 million and $11.9 million, respectively. The $31.2 million of refunds requested was offset by an increase in unrecognized tax benefits of $28.8 million due to the uncertainty of the outcome of an IRS examination. Because of the increase in unrecognized tax benefits, the refunds requested for 2016, 2017 and 2018 had no material impact on our effective tax rates in the 2020 and 2021 calendar years.

Following an IRS survey of the previously filed refund claims for the 2016, 2017 and 2018 tax years, the JCT approved such refunds in late January 2022. As a result, our benefit for income taxes in the first quarter of 2022 included a $28.8 million reduction in unrecognized tax benefits plus approximately $1.6 million of net interest income on the refunds.

Our benefit for income taxes in the first quarter of 2022 was further increased by $26.8 million for the expected refunds due to our intention to claim the R&D tax credit for the 2019, 2020 and 2021 tax years. In the third quarter of 2022, we claimed the R&D tax credit on our originally filed 2021 federal return and recognized an additional $1.7 million benefit for the 2019, 2020 and 2021 tax years. Additionally, in February 2023, we filed amended federal returns for 2019 and 2020 requesting refunds primarily from claiming the R&D tax credit.

The Inflation Reduction Act was enacted on August 16, 2022. This law, among other provisions, provides a corporate alternative minimum tax on adjusted financial statement income over $1 billion, which is effective for tax years beginning after December 31, 2022, and a 1% excise tax on net corporate stock repurchases after December 31, 2022. We currently believe these provisions will be immaterial to our overall financial results, financial position and cash flows.

Deferred Tax Assets (Liabilities)

Significant components of the deferred tax assets and deferred tax liabilities as reflected on the Consolidated Balance Sheets are as follows (in thousands):

Year Ended

 

December 31,

 

    

2022

    

2021

 

Deferred tax assets—

Accounts receivable and allowance for credit losses

$

2,530

$

1,878

Stock-based compensation

 

3,809

 

3,392

Accrued liabilities and expenses

34,179

36,255

Lease liabilities

 

32,048

 

27,944

Net operating loss carryforwards

5,361

10,379

Intangible assets

 

9,204

 

3,851

Research and experimental expenditures

106,002

Other

 

539

 

758

Subtotal

 

193,672

 

84,457

Valuation allowances

 

(379)

 

(475)

Total deferred tax assets

193,293

83,982

Deferred tax liabilities—

Property and equipment

 

(18,882)

 

(15,534)

Lease right-of-use asset

(32,025)

(27,905)

Long-term contracts

 

(1,870)

 

(964)

Goodwill

 

(23,288)

 

(17,321)

Other

 

(1,563)

 

(1,098)

Total deferred tax liabilities

 

(77,628)

 

(62,822)

Net deferred tax assets

$

115,665

$

21,160

The deferred tax assets and deferred tax liabilities reflected above are included in the Consolidated Balance Sheets as follows (in thousands):

December 31,

 

    

2022

    

2021

 

Deferred tax assets

$

115,665

$

22,905

Deferred tax liabilities

$

$

1,745

As of December 31, 2022, our deferred tax assets were primarily attributable to research and experimental (“R&E”) expenditures, accrued liabilities and expenses, intangible assets and net operating loss (“NOL”) carryforwards. Beginning in 2022, R&E expenditures must be capitalized and amortized pursuant to the Tax Cuts and Jobs Act (2017). Of the $5.4 million deferred tax asset for NOL carryforwards, $4.8 million is related to $23.1 million of federal NOL carryforwards from the TAS Energy Inc. (“TAS”) acquisition. If not used, such carryforwards will begin to expire in 2032.

Pursuant to Section 382 of the Internal Revenue Code, utilization of our federal NOL carryforwards is subject to annual limitations due to the ownership change in TAS. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain stockholders or public groups in the stock of a corporation by more than 50 percentage points over a three-year period.

Our management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit the use of the existing deferred tax assets. The most significant piece of objective evidence evaluated was three years of cumulative pretax income in the federal jurisdiction. Management determined there is sufficient positive evidence to conclude it is more likely than not our deferred tax assets are virtually all realizable.

Liabilities for Uncertain Tax Positions

A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):

Year Ended

 

December 31,

 

    

2022

    

2021

    

2020

 

Balance at beginning of year

$

29,452

$

28,756

$

10,199

Additions based on tax positions related to current year

 

3,420

 

207

 

Additions based on tax positions related to prior years

 

7,427

 

489

 

26,858

Reductions for tax positions related to prior years

 

(13)

 

 

Reductions for settlements with taxing authorities

 

(28,756)

 

 

(8,301)

Balance at end of year

$

11,530

$

29,452

$

28,756

As of December 31, 2022, 2021 and 2020, we had $11.5 million, $29.5 million and $28.8 million, respectively, of unrecognized tax benefits, which if recognized in future periods, would impact our effective tax rates. We also accrued $0.3 million for potential interest and penalties related to the unrecognized tax benefits as of December 31, 2022. We recognize potential interest and penalties related to unrecognized tax benefits in our provision for income taxes.

We are subject to taxation in the federal and various state jurisdictions. For the years ended December 31, 2022 and 2020, our unrecognized tax benefits were reduced by $28.8 million and $8.3 million, respectively, due to favorable settlements with the IRS for the 2014 through 2018 tax years. As of December 31, 2022, we remain open to IRS examination for the 2019 tax year forward.

State income tax returns are generally subject to examination for a period of three to four years after filing the returns. However, the state impact of any federal audit adjustments and/or amendments remains subject to examination by various states for up to one year after formal notification to the states. As of December 31, 2022, we generally remain open to examination by various state taxing authorities for the 2018 tax year forward.

We believe it is reasonably possible that a reduction of up to $5.3 million in unrecognized tax benefits could occur within the next twelve months. Any reductions in our unrecognized tax benefits, due to the future recognition of those tax benefits, would affect our effective tax rates.